All lobbying filings
SIDLEY AUSTIN LLP
SIDLEY AUSTIN LLP filed a Q3 report for INTERCEPT PHARMACEUTICALS, INC. on October 17, 2025, reporting no lobbying activity.
Lobbying for INTERCEPT PHARMACEUTICALS, INC. · Pharmaceutical manufacturer
Filing · LD-2 quarterly report
Q3 reportNo activity
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Lobbying activity
0
No itemized activity in this filing.